David Scott Saperstein
Presidente presso Phoenix Neurological Associates Ltd.
Provenienza dei contatti di primo grado di David Scott Saperstein
Entità | Tipo di entità | Settore Industriale | |
---|---|---|---|
Phoenix Neurological Associates Ltd.
Phoenix Neurological Associates Ltd. Medical/Nursing ServicesHealth Services Phoenix Neurological Associates Ltd. engages in treating patients with neurologic diseases. It specializes in alzheimers, amyotrophic lateral sclerosis, chronic inflammatory demyelinating polyneuropathy, dermatomyositis, epilepsy, guillain barre syndrome, headache, inclusion body myositis, movement disorders, multiple sclerosis and muscular dystrophy. The company is headquartered in Phoenix, AZ.
3
| Private Company | Medical/Nursing Services | 3 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a David Scott Saperstein tramite i suoi contatti personali
Società | Settore | Persone collegate | Posizione principale |
---|---|---|---|
Banner–University Medical Center Phoenix
Banner–University Medical Center Phoenix Medical/Nursing ServicesHealth Services Banner–University Medical Center Phoenix provides medical care, treatment and recovery services. It offers emergency, family healthcare, laboratory, wellness, and maternity. The company is headquartered in Phoenix, AZ. | Medical/Nursing Services | Corporate Officer/Principal | |
Cnd Life Sciences, Inc.
Cnd Life Sciences, Inc. Medical/Nursing ServicesHealth Services Cnd Life Sciences, Inc. is a company based in an undisclosed location that aims to transform the diagnosis and treatment of neurodegenerative diseases. The company is based in Scottsdale, AZ. The company operates a CLIA-certified and CAP-accredited laboratory and has launched the Syn-One test, the world's first commercially available test that detects and visualizes phosphorylated alpha-synuclein in cutaneous nerves with high accuracy to aid the diagnosis of Parkinson's disease and related disorders. Cnd Life Sciences has scientific collaborations with biopharmaceutical companies and has been awarded three NIH SBIR grants to advance the clinical utility of the Syn-One test. The company allows clinicians to access objective pathological insights on diseases that are often difficult to diagnose and apply those insights to generate better outcomes for patients. The company was founded in 2017 by Todd Dylan Levine, Christopher Gibbons, Roy Freeman, and the CEO is Richard J. Morello. | Medical/Nursing Services | Founder |
Statistiche
Distribuzione geografica
Stati Uniti | 3 |
Settori
Health Services | 3 |
Posizioni
Director/Board Member | 4 |
Corporate Officer/Principal | 1 |
Chief Tech/Sci/R&D Officer | 1 |
Founder | 1 |
Contatti più connessi
Insiders | |
---|---|
Todd Levine | 3 |
Harry S. Tamm | 1 |
Lori Hendin Travis | 1 |
- Borsa valori
- Insiders
- David Scott Saperstein
- Connessioni Società